Kourie J I
Membrane Transport Group, Department of Chemistry, The Faculties, The Australian National University, ACT, 0200, Canberra, Australia.
Chem Biol Interact. 2001 Oct 25;138(1):1-26. doi: 10.1016/s0009-2797(01)00228-9.
Prion-related encephalopathies are associated with the conversion of a normal cellular isoform of prion protein (PrP(c)) to an abnormal pathologic scrapie isoform (PrP(Sc)). The conversion of this single polypeptide chain involves a reduction in the alpha-helices and an increase in beta-sheet content. This change in the content ratio of alpha-helices to beta-sheets may explain the diversity in the proposed mechanisms of action. Many of the pathogenic properties of PrP(Sc), such as neurotoxicity, proteinase-resistant properties and induction of hypertrophy and proliferation of astrocytes, have been attributed to the peptide fragment corresponding to residues 106-126 of prion (PrP[106-126]). In particular, the amyloidogenic and hydrophobic core AGAAAAGA has been implicated in modulation of neurotoxicity and the secondary structure of PrP[106-126]. Because of some similarities between the properties of PrP[106-126] and PrP(Sc), the former is used as a useful tool to characterize the pharmacological and biophysical properties of PrP(Sc) in general and of that domain in particular, by various laboratories. However, it is important to note that by no means can PrP[106-126] be considered a complete equivalent to PrP(Sc) in function. Several hypotheses have been proposed to explain prion-induced neurodegenerative diseases. These non-exclusive hypotheses include: (i) changes in the membrane microviscosity; (ii) changes in the intracellular Ca(2+) homeostasis; (iii) superoxide dismutase and Cu(2+) homeostasis; and (iv) changes in the immune system. The prion-induced modification in Ca(2+) homeostasis is the result of: (1) prion interaction with intrinsic ion transport proteins, e.g. L-type Ca(2+) channels in the surface membrane, and IP(3)-modulated Ca(2+) channels in the internal membranes, and/or (2) formation of cation channels. These two mechanisms of action lead to changes in Ca(2+) homeostasis that further augment the abnormal electrical activity and the distortion of signal transduction causing cell death. It is concluded that the hypothesis of the interaction of PrP[106-126] with membranes and formation of redox-sensitive and pH-modulated heterogeneous ion channels is consistent with: (a) PrP-induced changes in membrane fluidity and viscosity; (b) PrP-induced changes in Ca(2+) homeostasis (and does not exclude changes in endogenous Ca(2+) transport pathways and Cu(2+) homeostasis); (c) PrP role as an antioxidant; and (d) the PrP structural properties, i.e. beta sheets, protein aggregation, hydrophobicity, functional significance of specific amino acids (e.g. methionine, histidine) and regulation with low pH.
朊病毒相关脑病与正常细胞型朊蛋白(PrP(c))转变为异常病理型瘙痒病朊蛋白(PrP(Sc))有关。这条单一多肽链的转变涉及α-螺旋减少和β-折叠含量增加。α-螺旋与β-折叠含量比例的这种变化可能解释了所提出的作用机制的多样性。PrP(Sc)的许多致病特性,如神经毒性、蛋白酶抗性以及诱导星形胶质细胞肥大和增殖,都归因于对应于朊蛋白106 - 126位残基的肽片段(PrP[106 - 126])。特别是,淀粉样生成和疏水核心AGAAAAGA与PrP[106 - 126]的神经毒性调节和二级结构有关。由于PrP[106 - 126]与PrP(Sc)的特性存在一些相似性,前者被各个实验室用作一种有用的工具,以总体上表征PrP(Sc)的药理和生物物理特性,特别是该结构域的特性。然而,需要注意的是,PrP[106 - 126]在功能上绝不能被视为与PrP(Sc)完全等同。已经提出了几种假说来解释朊病毒诱导的神经退行性疾病。这些并非相互排斥的假说包括:(i)膜微粘度的变化;(ii)细胞内Ca(2+)稳态的变化;(iii)超氧化物歧化酶和Cu(2+)稳态;以及(iv)免疫系统的变化。朊病毒诱导的Ca(2+)稳态改变是以下结果:(1)朊病毒与内在离子转运蛋白相互作用,例如表面膜中的L型Ca(2+)通道和内膜中IP(3)调节的Ca(2+)通道,和/或(2)阳离子通道的形成。这两种作用机制导致Ca(2+)稳态变化,进一步加剧异常电活动和信号转导畸变,从而导致细胞死亡。得出的结论是,PrP[106 - 126]与膜相互作用以及形成氧化还原敏感和pH调节的异质离子通道的假说与以下方面一致:(a)PrP诱导的膜流动性和粘度变化;(b)PrP诱导的Ca(2+)稳态变化(并且不排除内源性Ca(2+)转运途径和Cu(2+)稳态的变化);(c)PrP作为抗氧化剂的作用;以及(d)PrP的结构特性,即β-折叠、蛋白质聚集、疏水性、特定氨基酸(例如甲硫氨酸、组氨酸)的功能意义以及低pH调节。